Skip to content

Novo Nordisk op i fart - men tvivlen nager hos investorerne

August 11, 2026 · 37 min

Show notes

Novo Nordisk opjusterede forleden sine forventninger til 2026 markant,. Det skyldes bl.a., at salget af Wegovy-pillen er kommet virkelig stærkt fra start i USA. Alligevel sender investorerne aktien ned, mens ærkerivalen Eli Lilly vokser hurtigere og skruer op for presset på vægttabsmarkedet. I Bag Strategien gør vi status efter Mike Doustdars første år som topchef og spørger, om en stærkere pipeline, nye opkøb og bedre eksekvering kan bringe Novo tilbage i offensiven – og genoprette investorernes tillid. 

All episodes of Bag strategien

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.